Clinical Trials Directory

Trials / Completed

CompletedNCT02847975

Sodium Nitrate to Improve Blood Flow

Status
Completed
Phase
Phase 1
Study type
Interventional
Enrollment
11 (actual)
Sponsor
Cedars-Sinai Medical Center · Academic / Other
Sex
Male
Age
15 Years – 55 Years
Healthy volunteers
Accepted

Summary

Investigators recently showed that tadalafil restores functional sympatholysis in patients with Becker muscular dystrophy (BMD). If tadalafil restores functional sympatholysis in BMD via the NO-cyclic guanosine monophosphate pathway, then functional sympatholysis should also be restored by sodium nitrite- which is an indirect nitric oxide donor.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTSodium nitrateSodium nitrate will be ingested orally

Timeline

Start date
2013-10-01
Primary completion
2014-12-01
Completion
2014-12-01
First posted
2016-07-28
Last updated
2018-08-06

Locations

2 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT02847975. Inclusion in this directory is not an endorsement.

Sodium Nitrate to Improve Blood Flow (NCT02847975) · Clinical Trials Directory